BioRestorative Therapies, Inc. (BRTX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$356.7K
As of 2025-12-31
$3.03M
As of 2026-03-31
-67.4%
3-year compound annual growth
$21.60M2009-12-31: -$51.1K2010-12-31: -$744.2K2011-12-31: -$3.69M2012-12-31: -$5.14M2013-12-31: -$6.69M2014-12-31: -$6.89M2015-12-31: -$3.91M2016-12-31: -$5.00M2017-12-31: -$6.84M2018-12-31: -$8.64M2019-12-31: -$12.78M2020-12-31: -$1.33M2021-12-31: $21.60M2022-03-31: $5.95M2022-06-30: $12.16M2022-09-30: $9.78M2022-12-31: $10.29M2023-03-31: $6.46M2023-06-30: $2.64M2023-09-30: $10.76M2023-12-31: $10.00M2024-12-31: $8.53M2025-12-31: $356.7K$356.7K
2009-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$356.7K-95.8%2026-03-26, Balance as of period end
2024-12-31$8.53M-14.7%2026-03-26, Balance as of period end
2023-12-31$10.00Mn/a2025-03-28, Balance as of period end
2023-09-30$10.76Mn/a2024-06-11, Balance as of period end
2023-06-30$2.64Mn/a2024-06-11, Balance as of period end
2023-03-31$6.46Mn/a2024-06-11, Balance as of period end
2022-12-31$10.29Mn/a2024-06-11, Balance as of period end
2022-09-30$9.78Mn/a2024-06-11, Balance as of period end
2022-06-30$12.16Mn/a2024-06-11, Balance as of period end
2022-03-31$5.95Mn/a2024-06-11, Balance as of period end
2021-12-31$21.60Mn/m2023-03-27, Balance as of period end
2020-12-31-$1.33Mn/m2022-03-30, Balance as of period end
2019-12-31-$12.78Mn/m2021-04-30, Balance as of period end
2018-12-31-$8.64Mn/m2021-03-18, Balance as of period end
2017-12-31-$6.84Mn/m2019-03-29, Balance as of period end
2016-12-31-$5.00Mn/m2018-04-02, Balance as of period end
2015-12-31-$3.91Mn/m2017-03-22, Balance as of period end
2014-12-31-$6.89Mn/m2016-03-30, Balance as of period end
2013-12-31-$6.69Mn/m2015-03-31, Balance as of period end
2012-12-31-$5.14Mn/m2014-04-11, Balance as of period end
2011-12-31-$3.69Mn/m2014-04-11, Balance as of period end
2010-12-31-$744.2Kn/m2014-04-11, Balance as of period end
2009-12-31-$51.1Kn/a2014-04-11, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
BioRestorative Therapies, Inc. (BRTX)2025-12-31$356.7K-95.8%
Mangoceuticals, Inc. (MGRX)2025-12-31$15.20M+9.0%
Charming Medical Ltd (MCTA)2026-03-31$5.18Mn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$13.07M+11.9%
Marpai, Inc. (MRAI)2025-12-31-$32.56Mn/m
Cryo Cell International Inc (CCEL)2025-11-30-$18.61Mn/m
Viemed Healthcare, Inc. (VMD)2025-12-31$141.54M+7.7%
Sotera Health Co (SHC)2025-12-31$606.03M+49.7%
Progyny, Inc. (PGNY)2025-12-31$516.04M+22.3%

Compare BRTX, MGRX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗